LGVN
Longeveron Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.49
−8.12%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+197.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 25, 2026 | Jhaveri Nirav S. · officer: Chief Financial Officer | A-Award | 300,000 | $0.00 |
| Aug 21, 2026 | Hare Joshua · director, 10 percent owner, officer: Chief Scientific Officer | A-Award | 286,000 | $0.00 |
| Aug 21, 2026 | Agafonova Nataliya · officer: Chief Medical Officer | A-Award | 286,000 | $0.00 |
| Aug 21, 2026 | Blass Devin · officer: CTO & SVP of CMC | A-Award | 286,000 | $0.00 |
| Aug 21, 2026 | Desai Arjun JJ · director | A-Award | 36,000 | $0.00 |
| Aug 21, 2026 | Ungaro Ursula · director | A-Award | 36,000 | $0.00 |
| Aug 21, 2026 | Cann Leah Rush · director | A-Award | 36,000 | $0.00 |
| Aug 21, 2026 | Paletta George A. Jr. · director | A-Award | 36,000 | $0.00 |
| Aug 21, 2026 | Soffer Rock · director | A-Award | 36,000 | $0.00 |
| Aug 21, 2026 | Hajjar Roger Joseph · director | A-Award | 36,000 | $0.00 |
| Aug 21, 2026 | Ascheim Deborah · director | A-Award | 36,000 | $0.00 |
| Aug 21, 2026 | Lehr Paul T · officer: General Counsel, Secretary | A-Award | 286,000 | $0.00 |
| Jul 8, 2026 | Hare Joshua · director, 10 percent owner, officer: Chief Scientific Officer | A-Award | 400,000 | $0.65 |
| Jul 8, 2026 | Hare Joshua · director, 10 percent owner, officer: Chief Scientific Officer | A-Award | 600,000 | $0.00 |
| Jul 6, 2026 | Lehr Paul T · officer: General Counsel, Secretary | F-InKind | 13,143 | $0.73 |
| Jul 6, 2026 | Blass Devin · officer: CTO & SVP of CMC | F-InKind | 15,808 | $0.73 |
| Jul 6, 2026 | Agafonova Nataliya · officer: Chief Medical Officer | F-InKind | 22,505 | $0.73 |
| Jul 6, 2026 | Willard Stephen H · officer: Chief Executive Officer | F-InKind | 18,046 | $0.73 |
| Jul 6, 2026 | Locklear Lisa · officer: Chief Financial Officer | F-InKind | 22,505 | $0.73 |
| May 5, 2026 | Locklear Lisa · officer: Chief Financial Officer | A-Award | 250,000 | $0.00 |
| May 5, 2026 | Agafonova Nataliya · officer: Chief Medical Officer | A-Award | 250,000 | $0.00 |
| May 5, 2026 | Blass Devin · officer: CTO & SVP of CMC | A-Award | 250,000 | $0.00 |
| May 5, 2026 | Willard Stephen H · officer: Chief Executive Officer | A-Award | 500,000 | $0.00 |
| May 5, 2026 | Lehr Paul T · officer: General Counsel, Secretary | A-Award | 250,000 | $0.00 |
| Apr 3, 2026 | Blass Devin · officer: CTO & SVP of CMC | F-InKind | 8,633 | $1.12 |
| Apr 3, 2026 | Willard Stephen H · officer: Chief Executive Officer | F-InKind | 4,740 | $1.12 |
| Apr 3, 2026 | Locklear Lisa · officer: Chief Financial Officer | F-InKind | 13,145 | $1.12 |
| Apr 3, 2026 | Agafonova Nataliya · officer: Chief Medical Officer | F-InKind | 13,145 | $1.12 |
| Apr 3, 2026 | Lehr Paul T · officer: General Counsel, Secretary | F-InKind | 5,611 | $1.12 |
| Mar 13, 2026 | Willard Stephen H · officer: Chief Executive Officer | F-InKind | 105,533 | $0.55 |
Institutional positioning
13F filings over the trailing two quarters
New 25Increased 10Reduced 6Sold out 5
| Filer | Action | Shares | Filed |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | Increased | 1,353,881 | Aug 14, 2026 |
| Logos Global Management LP | New Position | 1,287,000 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 581,305 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 542,032 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | New Position | 446,725 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 224,198 | May 13, 2026 |
| BlackRock, Inc. | Reduced | 224,170 | Aug 7, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 203,761 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 203,618 | May 15, 2026 |
| ADAR1 CAPITAL MANAGEMENT, LLC | New Position | 200,000 | May 18, 2026 |
| JANE STREET GROUP, LLC | Increased | 190,370 | Aug 14, 2026 |
| JANE STREET GROUP, LLC | New Position | 185,656 | May 12, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Increased | 140,127 | Aug 13, 2026 |
| Mariner, LLC | New Position | 126,000 | Aug 13, 2026 |
| HRT FINANCIAL LP | Increased | 118,891 | May 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 25, 2026